DABUR2026-11-06DABUR2026-11-06ActionsTakenOrOrdersPassedDomain1DABUR2026-11-06ActionsTakenOrOrdersPassedDomain1PersonsAgainstWhomActionsTakenOrOrdersPassedDomain1DABUR2026-11-06SignatoriesDomain1xbrli:pureDABURDabur India Limited500096NOTLISTEDINE016A01026NewAction(s) taken or orders passed (sub-para 20)false2026-11-0612:40:002026-11-06Warning or CautionRegulatory AuthoritySecurities Exchnage Board of India1Listed Entity (Self)Dabur India LimitedAdministrative WarningAdministrative warning and advice letter received from SEBI by the Company, to be careful in future to avoid recurrence of such lapses i.e. delay in disclosure.2026-11-06The said warning letter alleges violation of Regulation 30(6)(iii) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 (“SEBI (LODR) Regulations”) on account of delay in making disclosure of warning letter received from US FDA on July 24, 2026 under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of SEBI (LODR) Regulations.TodayThere is no impact on the financial operations and other activities of the company due to aforesaid administrative warning letter issued by SEBI.The said warning letter alleges violation of Regulation 30(6)(iii) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 (“SEBI (LODR) Regulations”) on account of delay in making disclosure of warning letter received from US FDA on July 24, 2026 under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of SEBI (LODR) Regulations.NoneNot ApplicableIt is submitted that the Company has always been the most compliant in following all the SEBI Listing Regulations. The Company will take necessary steps to address the concern/directive mentioned in the aforesaid letter.Ashok Kumar JainCompliance Officer2026-11-06New Delhi